The Leadership Team at Chiasma is responsible for setting the strategic direction of the company and overseeing its operations to successfully advance the development and commercialization of innovative oral therapies for orphan diseases. This team, composed of key executives from various functional areas, collaborates to ensure regulatory compliance, market access, and effective communication with stakeholders, while driving clinical development and financial performance to enhance patient outcomes.
Asi Haviv
VP Clinical Development
Dan Thornton
VP Market Access and Patient S...
David Plante
VP Information Technology
Derek Brown
VP Marketing
Drew Enamait
VP Finance & Administration
Ethel Koczon
VP Clinical Operations
Mark J. Fitzpatrick
President
Raj Kannan
Chief Executive Officer
Shoshie Katz
VP Quality Assurance & Regulat...
William Ludlam
Senior VP Clinical Development...